ENVERIC BIOSCIENCES, INC. Debt Instrument, Face Amount
ENVERIC BIOSCIENCES, INC. (ENVB) had Debt Instrument, Face Amount of $3.10 million as of 2020-09-30, per its 10-Q filed 2020-11-16.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2020-11-16
- 2020-09-30: Debt Instrument, Face Amount $3.10M.
- 2020-06-30: Debt Instrument, Face Amount $2.30M.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2020-09-30 | $3.10M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $2.30M 10-Q · filed 2020-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |